GKOS logo

Glaukos Corporation (GKOS)

Profile

Full Name

Glaukos Corporation

Ticker

NYSE: GKOS

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

June 25, 2015

Indexes

Not included

Website

http://www.glaukos.com

Employees

995

Key Details

Price

$103.81(-2.57%)

Market cap

$5.93B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$383.48M(+21.85% YoY)

Annual EPS

-$2.77(+0.36% YoY)

PE ratio

-

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $103.81
    GKOS price is $103.81

    30-Day Relative Volume

    0.76
    GKOS 30-day relative volume is 0.76

    Price Performance

    Price Most recent change

    -2.57%
    GKOS price was down -2.57% on Jul 11, 2025

    Price YTD change

    -30.77%
    GKOS price is down -30.77% since January 1st

    Price 1-year change

    -15.77%
    GKOS price is down -15.77% year-on-year

    Price 3-year change

    +120.59%
    GKOS price is up +120.59% over the past 3 years

    Price Range

    Price All-time high

    $163.71
    GKOS price is currently -36.59% below its historical high of $163.71

    Price 3-year low

    $40.45
    GKOS price is currently +156.64% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.93B
    GKOS market capitalization is $5.93 billion

    Market cap 3-year change

    +165.81%
    GKOS market capitalization is up +165.81% over the past 3 years

    Market cap All-time high

    $9.25B
    GKOS market capitalization is currently -35.87% below its historical high of $9.25 billion

    Market cap sector rank

    89.59%
    GKOS market capitalization is higher than 89.59% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.23%
    GKOS shares outstanding is up +4.23% year-on-year

    Shares Outstanding 3-Year Change

    +20.5%
    GKOS shares outstanding is up +20.5% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.46
    GKOS beta is 1.46

    200-day SMA

    $121.17
    GKOS price is currently -14.33% below its 200-day simple moving average

    50-day SMA

    $96.40
    GKOS price is currently +7.69% above its 50-day simple moving average

    RSI

    57.60
    GKOS 14-day relative strength index is 57.60

    Volume

    0.76
    GKOS 30-day relative volume is 0.76

    ATR

    $3.23
    GKOS average true range is $3.23

    10-day Historical Volatility

    25.90%
    GKOS 10-day historical volatility is 25.90%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $383.48M
    GKOS annual revenue is $383.48 million

    Revenue Analysts estimate

    $480.78M
    GKOS annual revenue is currently -20.24% lower than the consensus analysts' forecast

    Revenue 1-year change

    +21.85%
    GKOS annual revenue is up +21.85% year-on-year

    Revenue Sector rank

    70.56%
    GKOS annual revenue is higher than 70.56% of companies in Healthcare sector

    EPS

    EPS

    -$2.77
    GKOS annual earnings per share is -$2.77

    EPS Analysts estimate

    -$0.86
    GKOS annual earnings per share is currently +220.60% higher than the consensus analysts' forecast

    EPS 1-year change

    +0.36%
    GKOS annual earnings per share is up +0.36% year-on-year

    EPS Sector rank

    32.11%
    GKOS annual earnings per share is higher than 32.11% of companies in Healthcare sector

    Profit

    Gross profit

    $289.45M
    GKOS annual gross profit is $289.45 million

    Gross margin

    75.48%
    GKOS annual gross profit margin is 75.48%

    Operating profit

    -$108.14M
    GKOS annual operating income is -$108.14 million

    Operating margin

    -28.20%
    GKOS annual operating profit margin is -28.20%

    Net income

    -$146.37M
    GKOS annual net profit is -$146.37 million

    Net margin

    -38.17%
    GKOS annual net profit margin is -38.17%

    Expenses

    Total expenses

    $491.62M
    GKOS annual total expenses is $491.62 million

    Operating expenses

    $397.59M
    GKOS annual total operating expenses is $397.59 million

    Cost of goods sold

    $94.03M
    GKOS annual cost of goods sold is $94.03 million

    Selling, general & administrative expenses

    $261.17M
    GKOS annual SGA is $261.17 million

    Depreciation and amortization

    $39.92M
    GKOS annual depreciation & amortization is $39.92 million

    Interest expense

    $10.04M
    GKOS annual interest expense is $10.04 million

    Income tax

    $771.00K
    GKOS annual income tax is $771.00 thousand

    EBIT & EBITDA

    EBIT

    -$135.56M
    GKOS annual earnings before interest & taxes is -$135.56 million

    EBITDA

    -$135.56M
    GKOS annual EBITDA is -$135.56 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $974.76M
    GKOS annual total assets is $974.76 million

    Non current assets

    $524.96M
    GKOS annual long term assets is $524.96 million

    Current assets

    $449.79M
    GKOS annual total current assets is $449.79 million

    Cash and cash equivalents

    $169.63M
    GKOS annual cash & cash equivalents is $169.63 million

    Accounts receivable

    $60.74M
    GKOS annual accounts receivable is $60.74 million

    Inventory

    $57.68M
    GKOS annual inventory is $57.68 million

    Liabilities

    Total liabilities

    $207.82M
    GKOS annual total liabilities is $207.82 million

    Long term liabilities

    $132.70M
    GKOS annual total long term liabilities is $132.70 million

    Current liabilities

    $75.13M
    GKOS annual total current liabilities is $75.13 million

    Accounts payable

    $13.03M
    GKOS annual accounts payable is $13.03 million

    Debt

    Total debt

    $103.40M
    GKOS annual total debt is $103.40 million

    Total debt 1-year change

    -73.05%
    GKOS annual total debt is down -73.05% year-on-year

    Long term debt

    $103.40M
    GKOS annual long term debt is $103.40 million

    Short term debt

    -
    GKOS annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $766.93M
    GKOS annual stockholders equity is $766.93 million

    Book value

    $766.93M
    GKOS annual book value is $766.93 million

    Retained earnings

    -$745.44M
    GKOS annual retained earnings is -$745.44 million

    Working capital

    $374.67M
    GKOS annual working capital is $374.67 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$61.32M
    GKOS annual cash flow from operations is -$61.32 million

    Cash from operations 1-year change

    -6.16%
    GKOS annual cash flow from operations is down -6.16% year-on-year

    Cash from investing

    $47.83M
    GKOS annual cash flow from investing activities is $47.83 million

    Cash from investing 1-year change

    +239.35%
    GKOS annual cash flow from investing activities is up +239.35% year-on-year

    Cash from financing

    $91.54M
    GKOS annual cash flow from financing activities is $91.54 million

    Cash from financing 1-year change

    +508.56%
    GKOS annual cash flow from financing activities is up +508.56% year-on-year

    CAPEX

    CAPEX

    $6.30M
    GKOS annual capital expenditures is $6.30 million

    CAPEX 1-year change

    -68.89%
    GKOS annual capital expenditures is down -68.89% year-on-year

    Free Cash Flow

    Free cash flow

    -$67.62M
    GKOS annual free cash flow is -$67.62 million

    Free cash flow 1-year change

    +13.32%
    GKOS annual free cash flow is up +13.32% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    75.48%
    GKOS annual gross profit margin is 75.48%

    Operating margin

    -28.20%
    GKOS annual operating profit margin is -28.20%

    Net margin

    -38.17%
    GKOS annual net profit margin is -38.17%

    ROA & ROE

    ROA

    -15.29%
    GKOS annual return on assets is -15.29%

    ROE

    -23.83%
    GKOS annual return on equity is -23.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    GKOS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    GKOS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    7.76
    GKOS price to book ratio is 7.76

    PB ratio Sector rank

    86.77%
    GKOS price to book ratio is higher than 86.77% of companies in Healthcare sector

    PS Ratio

    PS ratio

    14.66
    GKOS price to sales ratio is 14.66

    PS ratio Sector rank

    82.04%
    GKOS price to sales ratio is higher than 82.04% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.92B
    GKOS enterprise value is $5.92 billion

    Enterprise value Sector rank

    88.83%
    GKOS enterprise value is higher than 88.83% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -77.97
    GKOS EV/EBITDA is -77.97

    EV/EBITDA Sector rank

    2.55%
    GKOS EV/EBITDA is higher than 2.55% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.99
    GKOS annual current ratio is 5.99

    Quick ratio

    5.22
    GKOS annual quick ratio is 5.22

    Leverage

    Debt to equity

    0.00
    GKOS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -13.50
    GKOS annual interest coverage ratio is -13.50

    Risk & Stability

    Piotroski F-Score

    5
    GKOS piotroski f-score is 5

    Altman Z-Score

    16.45
    GKOS altman z-score is 16.45

    Analyst ratings

    Recent major analysts updates

    May 6, 25 Morgan Stanley
    Underweight
    May 2, 25 Stephens & Co.
    Overweight
    May 1, 25 Wells Fargo
    Equal-Weight
    May 1, 25 Truist Securities
    Buy
    May 1, 25 Stifel
    Buy
    May 1, 25 Needham
    Buy
    Apr 16, 25 Mizuho
    Outperform
    Apr 15, 25 Piper Sandler
    Overweight
    Apr 11, 25 Truist Securities
    Buy
    Feb 21, 25 Wells Fargo
    Overweight

    Institutional Ownership

    Screeners with GKOS included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Glaukos Corporation?
    • Does Glaukos Corporation pay dividends?
    • What sector is Glaukos Corporation in?
    • What industry is Glaukos Corporation in?
    • What country is Glaukos Corporation based in?
    • When did Glaukos Corporation go public?
    • Is Glaukos Corporation in the S&P 500?
    • Is Glaukos Corporation in the NASDAQ 100?
    • Is Glaukos Corporation in the Dow Jones?
    • When was Glaukos Corporation's last earnings report?
    • When does Glaukos Corporation report earnings?

    What is the ticker symbol for Glaukos Corporation?

    The ticker symbol for Glaukos Corporation is NYSE:GKOS

    Does Glaukos Corporation pay dividends?

    No, Glaukos Corporation does not pay dividends

    What sector is Glaukos Corporation in?

    Glaukos Corporation is in the Healthcare sector

    What industry is Glaukos Corporation in?

    Glaukos Corporation is in the Medical Devices industry

    What country is Glaukos Corporation based in?

    Glaukos Corporation is headquartered in United States

    When did Glaukos Corporation go public?

    Glaukos Corporation's initial public offering (IPO) was on June 25, 2015

    Is Glaukos Corporation in the S&P 500?

    No, Glaukos Corporation is not included in the S&P 500 index

    Is Glaukos Corporation in the NASDAQ 100?

    No, Glaukos Corporation is not included in the NASDAQ 100 index

    Is Glaukos Corporation in the Dow Jones?

    No, Glaukos Corporation is not included in the Dow Jones index

    When was Glaukos Corporation's last earnings report?

    Glaukos Corporation's most recent earnings report was on April 30, 2025

    When does Glaukos Corporation report earnings?

    The next expected earnings date for Glaukos Corporation is July 31, 2025
    On this page